tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRNX Stock Latest News

Crinetics price target raised to $84 from $75 at Stifel
The FlyCrinetics price target raised to $84 from $75 at Stifel
1d ago
CRNX
Crinetics doses first patient in BALANCE-CAH trial
PremiumThe Fly
Crinetics doses first patient in BALANCE-CAH trial
9d ago
CRNX
‘Markets Climb Wall-of-Worry’: Oppenheimer Sees Resilience Driving 2026 and Suggests 2 Stocks to Buy
PremiumStock Analysis & Ideas
‘Markets Climb Wall-of-Worry’: Oppenheimer Sees Resilience Driving 2026 and Suggests 2 Stocks to Buy
15d ago
AMPX
CRNX
Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline
PremiumCompany Announcements
Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline
18d ago
8K
CRNX
Crinetics Pharmaceuticals: Phase 2 TouCAHn De‑Risking and Optimized Phase 3 Design Drive Upgrade to Buy and $67 Target
PremiumRatings
Crinetics Pharmaceuticals: Phase 2 TouCAHn De‑Risking and Optimized Phase 3 Design Drive Upgrade to Buy and $67 Target
18d ago
CRNX
Crinetics upgraded to Buy from Neutral at Goldman Sachs
PremiumThe FlyCrinetics upgraded to Buy from Neutral at Goldman Sachs
19d ago
CRNX
Crinetics price target raised to $87 from $80 at Morgan Stanley
Premium
The Fly
Crinetics price target raised to $87 from $80 at Morgan Stanley
23d ago
CRNX
Crinetics price target lowered to $105 from $108 at Citizens
Premium
The Fly
Crinetics price target lowered to $105 from $108 at Citizens
23d ago
CRNX
Crinetics Announces Major Public Offering to Fund Growth
PremiumCompany Announcements
Crinetics Announces Major Public Offering to Fund Growth
24d ago
8K
CRNX
Crinetics rises 14.7%
PremiumThe Fly
Crinetics rises 14.7%
24d ago
CRNX
Midday Fly By: Warner Bros. urges holders to reject Paramount bid
PremiumThe Fly
Midday Fly By: Warner Bros. urges holders to reject Paramount bid
24d ago
W
BA
Crinetics rises 12.8%
PremiumThe Fly
Crinetics rises 12.8%
24d ago
CRNX
Crinetics 7.62M share Secondary priced at $45.95
PremiumThe FlyCrinetics 7.62M share Secondary priced at $45.95
24d ago
CRNX
Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
Premium
Company Announcements
Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
26d ago
8K
CRNX
Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
Premium
Ratings
Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
26d ago
CRNX
Crinetics announces $350M common stock offering
PremiumThe Fly
Crinetics announces $350M common stock offering
26d ago
CRNX
Crinetics price target raised to $97 from $85 at JonesResearch
PremiumThe Fly
Crinetics price target raised to $97 from $85 at JonesResearch
26d ago
CRNX
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
PremiumThe Fly
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
26d ago
TM
ALT
Crinetics (CRNX): Robust Atumelnant CAH Data, De-Risked Phase 3, and Strong Execution Underpin Buy Rating
PremiumRatings
Crinetics (CRNX): Robust Atumelnant CAH Data, De-Risked Phase 3, and Strong Execution Underpin Buy Rating
26d ago
CRNX
Crinetics price target raised to $90 from $80 at Evercore ISI
PremiumThe FlyCrinetics price target raised to $90 from $80 at Evercore ISI
26d ago
CRNX
RBC Capital would be a buyer of Neurocrine on weakness following competitor data
Premium
The Fly
RBC Capital would be a buyer of Neurocrine on weakness following competitor data
26d ago
CRNX
NBIX
Crinetics reports Q4 PALSONIFY U.S. preliminary net product revenue of over $5M
Premium
The Fly
Crinetics reports Q4 PALSONIFY U.S. preliminary net product revenue of over $5M
26d ago
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >